BriaCell Therapeutics Corp (BCTXW) — Cash Flow-to-Debt Ratio
BriaCell Therapeutics Corp (BCTXW) has a Cash Flow-to-Debt Ratio of -2.41x as of January 2026, meaning its operating cash flow of $-8.09 Million could theoretically repay -2% of its total liabilities ($3.35 Million) in one year. See financial agility of BriaCell Therapeutics Corp to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BriaCell Therapeutics Corp Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for BriaCell Therapeutics Corp across 20 annual periods. For the full cash flow conversion analysis, see BriaCell Therapeutics Corp cash flow conversion.
Annual Cash Flow-to-Debt Ratio for BriaCell Therapeutics Corp (2006–2025)
Year-by-year debt coverage analysis for BriaCell Therapeutics Corp. Check BriaCell Therapeutics Corp earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.53x | $-28.17 Million | $4.32 Million | ▼ -131.5% |
| 2024 | -2.82x | $-24.13 Million | $8.56 Million | ▼ -267.4% |
| 2023 | -0.77x | $-23.74 Million | $30.94 Million | ▼ -98.2% |
| 2022 | -0.39x | $-12.48 Million | $32.25 Million | ▲ +96.1% |
| 2021 | -9.90x | $-7.75 Million | $782.24K | ▼ -3123.4% |
| 2020 | -0.31x | $-1.16 Million | $3.77 Million | ▲ +91.6% |
| 2019 | -3.66x | $-3.87 Million | $1.06 Million | ▼ -28.8% |
| 2018 | -2.84x | $-3.81 Million | $1.34 Million | ▼ -63.9% |
| 2017 | -1.73x | $-1.54 Million | $885.90K | ▲ +93.0% |
| 2016 | -24.68x | $-1.20 Million | $48.59K | ▼ -209.2% |
| 2015 | -7.98x | $-935.26K | $117.17K | ▼ -3930.2% |
| 2014 | -0.20x | $-363.97K | $1.84 Million | ▲ +96.0% |
| 2013 | -4.95x | $-368.52K | $74.46K | ▼ -268.4% |
| 2012 | -1.34x | $-381.49K | $283.94K | ▼ -8.8% |
| 2011 | -1.23x | $-690.76K | $559.43K | ▲ +88.4% |
| 2010 | -10.61x | $-309.37K | $29.15K | ▼ -384.5% |
| 2009 | -2.19x | $-140.59K | $64.19K | ▲ +60.8% |
| 2008 | -5.59x | $-87.41K | $15.64K | ▲ +39.0% |
| 2007 | -9.16x | $-87.76K | $9.58K | ▼ -13543.1% |
| 2006 | 0.07x | $1.13K | $16.54K | — |